Discovery proteomics identifies a molecular link between the coatomer protein complex I and androgen receptor-dependent transcription

Journal of Biological Chemistry

Volumn 291, Issue 36, 2016, Pages 18818-18842

  Hsiao, Jordy J ^a   Smits, Melinda M ^a   Ng, Brandon H ^a   Lee, Jinhee ^a   Wright, Michael E ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINS; BIOACTIVITY; CELL CULTURE; CELLS; CHEMICAL ACTIVATION; CYTOLOGY; DISEASES; LIGANDS; MASS SPECTROMETRY; MOLECULAR BIOLOGY; PEPTIDES; RECOMBINANT PROTEINS; TRANSCRIPTION; TUMORS; UROLOGY;

ANDROGEN RECEPTORS; CYTOSOLIC PROTEINS; HUMAN PROSTATE CANCER; MEDIATED TRANSCRIPTION; PROTEIN COMPLEXES; PROTEIN-PROTEIN INTERACTIONS; QUANTITATIVE MASS SPECTROMETRIES; TRANSCRIPTIONAL ACTIVATIONS;

PROTEINS;

ANDROGEN RECEPTOR; COATOMER PROTEIN; COATOMER PROTEIN COMPLEX 1; UNCLASSIFIED DRUG; COAT PROTEIN COMPLEX I; DNA BINDING PROTEIN; TMF1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGAND BINDING; LNCAP CELL LINE; MALE; MASS SPECTROMETRY; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; RECEPTOR BINDING; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; CELL NUCLEUS; GENETIC TRANSCRIPTION; GENETICS; GOLGI COMPLEX; METABOLISM; NUCLEOCYTOPLASMIC TRANSPORT; PROSTATE TUMOR; TUMOR CELL LINE;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL LINE, TUMOR; CELL NUCLEUS; COAT PROTEIN COMPLEX I; DNA-BINDING PROTEINS; GOLGI APPARATUS; HUMANS; MALE; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; PROTEOMICS; RECEPTORS, ANDROGEN; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84984873616     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M116.732313     Document Type: Article

References (104)

1. Heemers, H. V., and Tindall, D. J. (2007) Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex. Endocr. Rev. 28, 778-808
2. Heinlein, C. A., and Chang, C. (2004) Androgen receptor in prostate cancer. Endocr. Rev. 25, 276-308
3. Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X. W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., Lee, C., Montie, J. E., Shah, R. B., Pienta, K. J., Rubin, M. A., and Chinnaiyan, A. M. (2005) Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310, 644-648
4. Tomlins, S. A., Laxman, B., Varambally, S., Cao, X., Yu, J., Helgeson, B. E., Cao, Q., Prensner, J. R., Rubin, M. A., Shah, R. B., Mehra, R., and Chinnaiyan, A. M. (2008) Role of the TMPRSS2-ERG gene fusion in prostate cancer. Neoplasia 10, 177-188
5. Chen, Y., Chi, P., Rockowitz, S., Iaquinta, P. J., Shamu, T., Shukla, S., Gao, D., Sirota, I., Carver, B. S., Wongvipat, J., Scher, H. I., Zheng, D., and Sawyers, C. L. (2013) ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss. Nat. Med. 19, 1023-1029
6. Baena, E., Shao, Z., Linn, D. E., Glass, K., Hamblen, M. J., Fujiwara, Y., Kim, J., Nguyen, M., Zhang, X., Godinho, F. J., Bronson, R. T., Mucci, L. A., Loda, M., Yuan, G.-C., Orkin, S. H., and Li, Z. (2013) ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients. Genes Dev. 27, 683-698
7. Arora, V. K., Schenkein, E., Murali, R., Subudhi, S. K., Wongvipat, J., Balbas, M. D., Shah, N., Cai, L., Efstathiou, E., Logothetis, C., Zheng, D., and Sawyers, C. L. (2013) Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade. Cell 155, 1309-1322
8. Eichholz, A., Ferraldeschi, R., Attard, G., and De Bono, J. S. (2012) Putting the brakes on continued androgen receptor signaling in castration-resistant prostate cancer. Mol. Cell. Endocrinol. 360, 68-75
9. Cookson, M. S., Roth, B. J., Dahm, P., Engstrom, C., Freedland, S. J., Hussain, M., Lin, D. W., Lowrance, W. T., Murad, M. H., Oh, W. K., Penson, D. F., and Kibel, A. S. (2013) Castration-resistant prostate cancer: AUA guideline. J. Urol. 190, 429-438
10. Bahl, A., Masson, S., Birtle, A., Chowdhury, S., and De Bono, J. (2014) Second-line treatment options in metastatic castration-resistant prostate cancer: a comparison of key trials with recently approved agents. Cancer Treat. Rev. 40, 170-177
11. Prescott, J., and Coetzee, G. A. (2006) Molecular chaperones throughout the life cycle of the androgen receptor. Cancer Lett. 231, 12-19
12. Kaku, N., Matsuda, K., Tsujimura, A., and Kawata, M. (2008) Characterization of nuclear import of the domain-specific androgen receptor in association with the importin α/β and Ran-guanosine 5'-triphosphate systems. Endocrinology 149, 3960-3969
13. Chatr-Aryamontri, A., Breitkreutz, B. J., Oughtred, R., Boucher, L., Heinicke, S., Chen, D., Stark, C., Breitkreutz, A., Kolas, N., O'Donnell, L., Reguly, T., Nixon, J., Ramage, L., Winter, A., Sellam, A., et al. (2015) The BioGRID interaction database: 2015 update. Nucleic Acids Res. 43, D470-D478
14. Franceschini, A., Szklarczyk, D., Frankild, S., Kuhn, M., Simonovic, M., Roth, A., Lin, J., Minguez, P., Bork, P., Von Mering, C., and Jensen, L. J. (2013) STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 41, D808-D815
15. Gottlieb, B., Beitel, L. K., Nadarajah, A., Paliouras, M., and Trifiro, M. (2012) The androgen receptor gene mutations database: 2012 update. Hum. Mutat. 33, 887-894
16. Peri, S., Navarro, J. D., Amanchy, R., Kristiansen, T. Z., Jonnalagadda, C. K., Surendranath, V., Niranjan, V., Muthusamy, B., Gandhi, T. K. B., Gronborg, M., Ibarrola, N., Deshpande, N., Shanker, K., Shivashankar, H. N., Rashmi, B. P., et al. (2003) Development of Human Protein Reference Database as an Initial Platform for Approaching Systems Biology in Humans. Genome Res. 13, 2363-2371
17. Veldscholte, J., Ris-Stalpers, C., Kuiper, G. G., Jenster, G., Berrevoets, C., Claassen, E., Van Rooij, H. C., Trapman, J., Brinkmann, A. O., and Mulder, E. (1990) A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem. Biophys. Res. Commun. 173, 534-540
18. Keefe, A. D., Wilson, D. S., Seelig, B., and Szostak, J. W. (2001) One-step purification of recombinant proteins using a nanomolar-affinity streptavidinbinding peptide, the SBP-Tag. Protein Expr. Purif. 23, 440-446
19. Johnson, K. Y., Liu, L., and Vincent, T. S. (2002) Minimal FLAG sequence useful in the functional epitope tagging of H-Ras. BioTechniques 32, 1270, 1272-1276, 1278, 1280
20. Veldscholte, J., Berrevoets, C. A., Brinkmann, A. O., Grootegoed, J. A., and Mulder, E. (1992) Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation. Biochemistry 31, 2393-2399
21. Martinez, H. D., Hsiao, J. J., Jasavala, R. J., Hinkson, I. V., Eng, J. K., and Wright, M. E. (2011) Androgen-sensitive microsomal signaling networks coupled to the proliferation and differentiation of human prostate cancer cells. Genes Cancer 2, 956-978
22. Schmidt, A., Beck, M., Malmström, J., Lam, H., Claassen, M., Campbell, D., and Aebersold, R. (2011) Absolute quantification of microbial proteomes at different states by directed mass spectrometry. Mol. Syst. Biol. 7, 510
23. Rudomin, E. L., Carr, S. A., and Jaffe, J. D. (2009) Directed sample interrogation utilizing an accurate mass exclusion-based data-dependent acquisition strategy (AMEx). J. Proteome Res. 8, 3154-3160
24. Schmidt, A., Claassen, M., and Aebersold, R. (2009) Directed mass spectrometry: towards hypothesis-driven proteomics. Curr. Opin. Chem. Biol. 13, 510-517
25. Schmidt, A., Gehlenborg, N., Bodenmiller, B., Mueller, L. N., Campbell, D., Mueller, M., Aebersold, R., and Domon, B. (2008) An integrated, directed mass spectrometric approach for in-depth characterization of complex peptide mixtures. Mol. Cell. Proteomics 7, 2138-2150
26. Wiśniewski, J. R., Zougman, A., Nagaraj, N., and Mann, M. (2009) Universal sample preparation method for proteome analysis. Nat. Methods 6, 359-362
27. Tyagi, R. K., Lavrovsky, Y., Ahn, S. C., Song, C. S., Chatterjee, B., and Roy, A. K. (2000) Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells. Mol. Endocrinol. 14, 1162-1174
28. Omasits, U., Quebatte, M., Stekhoven, D. J., Fortes, C., Roschitzki, B., Robinson, M. D., Dehio, C., and Ahrens, C. H. (2013) Directed shotgun proteomics guided by saturated RNA-seq identifies a complete expressed prokaryotic proteome. Genome Res. 23, 1916-1927
29. Wang, J., Duncan, D., Shi, Z., and Zhang, B. (2013) WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nucleic Acids Res. 41, W77-W83
30. Lin, H.-K., Altuwaijri, S., Lin, W.-J., Kan, P.-Y., Collins, L. L., and Chang, C. (2002) Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells. J. Biol. Chem. 277, 36570-36576
31. Kabler, R. L., Srinivasan, A., Taylor, L. J., Mowad, J., Rothblum, L. I., and Cavanaugh, A. H. (1996) Androgen regulation of ribosomalRNAsynthesis in LNCaP cells and rat prostate. J. Steroid Biochem. Mol. Biol. 59, 431-439
32. Liang, T., and Liao, S. (1975) A very rapid effect of androgen on initiation of protein synthesis in prostate. Proc. Natl. Acad. Sci. U. S. A. 72, 706-709
33. Wilhelm, M., Schlegl, J., Hahne, H., Moghaddas Gholami, A., Lieberenz, M., Savitski, M. M., Ziegler, E., Butzmann, L., Gessulat, S., Marx, H., Mathieson, T., Lemeer, S., Schnatbaum, K., Reimer, U., Wenschuh, H., et al. (2014) Mass-spectrometry-based draft of the human proteome. Nature 509, 582-587
34. Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., and Ideker, T. (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498-2504
35. Saito, R., Smoot, M. E., Ono, K., Ruscheinski, J., Wang, P. L., Lotia, S., Pico, A. R., Bader, G. D., and Ideker, T. (2012) Atravel guide to Cytoscape plugins. Nat. Methods 9, 1069-1076
36. Cowley, M. J., Pinese, M., Kassahn, K. S., Waddell, N., Pearson, J. V., Grimmond, S. M., Biankin, A. V., Hautaniemi, S., and Wu, J. (2012) PINA v2.0: mining interactome modules. Nucleic Acids Res. 40, D862-D865
37. Shi, Z., Wang, J., and Zhang, B. (2013) NetGestalt: integrating multidimensional omics data over biological networks. Nat. Methods 10, 597-598
38. Loikkanen, I., Toljamo, K., Hirvikoski, P., Väisänen, T., Paavonen, T. K., and Vaarala, M. H. (2009) Myosin VI is a modulator of androgen-dependent gene expression. Oncol. Rep. 22, 991-995
39. Darshan, M. S., Loftus, M. S., Thadani-Mulero, M., Levy, B. P., Escuin, D., Zhou, X. K., Gjyrezi, A., Chanel-Vos, C., Shen, R., Tagawa, S. T., Bander, N. H., Nanus, D. M., and Giannakakou, P. (2011) Taxane-induced blockade to nuclear accumulation of the androgen receptor predicts clinical responses in metastatic prostate cancer. Cancer Res. 71, 6019-6029
40. Zhu, M. L., Horbinski, C. M., Garzotto, M., Qian, D. Z., Beer, T. M., and Kyprianou, N. (2010) Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer. Cancer Res. 70, 7992-8002
41. Loy, C. J., Sim, K. S., and Yong, E. L. (2003) Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functions. Proc. Natl. Acad. Sci. U. S. A. 100, 4562-4567
42. Ozanne, D. M., Brady, M. E., Cook, S., Gaughan, L., Neal, D. E., and Robson, C. N. (2000) Androgen receptor nuclear translocation is facilitated by the F-actin cross-linking protein filamin. Mol. Endocrinol. 14, 1618-1626
43. Cardozo, C. P., Michaud, C., Ost, M. C., Fliss, A. E., Yang, E., Patterson, C., Hall, S. J., and Caplan, A. J. (2003) C-terminal Hsp-interacting protein slows androgen receptor synthesis and reduces its rate of degradation. Arch. Biochem. Biophys. 410, 134-140
44. Faus, H., Meyer, H. A., Huber, M., Bahr, I., and Haendler, B. (2005) The ubiquitin-specific protease USP10 modulates androgen receptor function. Mol. Cell. Endocrinol. 245, 138-146
45. Rees, I., Lee, S., Kim, H., and Tsai, F. T. (2006) The E3 ubiquitin ligase CHIP binds the androgen receptor in a phosphorylation-dependent manner. Biochim. Biophys. Acta 1764, 1073-1079
46. Sheflin, L., Keegan, B., Zhang, W., and Spaulding, S. W. (2000) Inhibiting proteasomes in human HepG2 and LNCaP cells increases endogenous androgen receptor levels. Biochem. Biophys. Res. Commun. 276, 144-150
47. Deroo, B. J., Rentsch, C., Sampath, S., Young, J., DeFranco, D. B., and Archer, T. K. (2002) Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking. Mol. Cell. Biol. 22, 4113-4123
48. Powers, G. L., Ellison-Zelski, S. J., Casa, A. J., Lee, A. V., and Alarid, E. T. (2010) Proteasome inhibition represses ERα gene expression in ER+ cells: a new link between proteasome activity and estrogen signaling in breast cancer. Oncogene 29, 1509-1518
49. Lander, G. C., Estrin, E., Matyskiela, M. E., Bashore, C., Nogales, E., and Martin, A. (2012) Complete subunit architecture of the proteasome regulatory particle. Nature 482, 186-191
50. Pemberton, L. F., and Paschal, B. M. (2005) Mechanisms of receptormediated nuclear import and nuclear export. Traffic 6, 187-198
51. Cutress, M. L., Whitaker, H. C., Mills, I. G., Stewart, M., and Neal, D. E. (2008) Structural basis for the nuclear import of the human androgen receptor. J. Cell Sci. 121, 957-968
52. Ni, L., Llewellyn, R., Kesler, C. T., Kelley, J. B., Spencer, A., Snow, C. J., Shank, L., and Paschal, B. M. (2013) Androgen induces a switch from cytoplasmic retention to nuclear import of the androgen receptor. Mol. Cell. Biol. 33, 4766-4778
53. Morfini, G., Pigino, G., Szebenyi, G., You, Y., Pollema, S., and Brady, S. T. (2006) JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport. Nat. Neurosci. 9, 907-916
54. Cosson, P., and Letourneur, F. (1997) Coatomer (COPI)-coated vesicles: role in intracellular transport and protein sorting. Curr. Opin. Cell Biol. 9, 484-487
55. Lee, C., and Goldberg, J. (2010) Structure of coatomer cage proteins and the relationship among COPI, COPII, and clathrin vesicle coats. Cell 142, 123-132
56. Seaman, M. N. (2012) The retromer complex: endosomal protein recycling and beyond. J. Cell Sci. 125, 4693-4702
57. Gioeli, D., and Paschal, B. M. (2012) Post-translational modification of the androgen receptor. Mol. Cell. Endocrinol. 352, 70-78
58. An, J., Wang, C., Deng, Y., Yu, L., and Huang, H. (2014) Destruction of full-length androgen receptor by wild-type SPOP, but not prostate-cancerassociated mutants. Cell Rep. 6, 657-669
59. He, B., Bai, S., Hnat, A. T., Kalman, R. I., Minges, J. T., Patterson, C., and Wilson, E. M. (2004) An androgen receptor NH2-terminal conserved motif interacts with the COOH terminus of the Hsp70-interacting protein (CHIP). J. Biol. Chem. 279, 30643-30653
60. Lin, H.-K., Wang, L., Hu, Y.-C., Altuwaijri, S., and Chang, C. (2002) Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. EMBO J. 21, 4037-4048
61. Xu, K., Shimelis, H., Linn, D. E., Jiang, R., Yang, X., Sun, F., Guo, Z., Chen, H., Li, W., Chen, H., Kong, X., Melamed, J., Fang, S., Xiao, Z., Veenstra, T. D., and Qiu, Y. (2009) Regulation of androgen receptor transcriptional activity and specificity by RNF6-induced ubiquitination. Cancer Cell 15, 270-282
62. Spiro, R. G. (2002) Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. Glycobiology 12, 43R-56R
63. Pedram, A., Razandi, M., Deschenes, R. J., and Levin, E. R. (2012) DHHC-7 and -21 are palmitoylacyltransferases for sex steroid receptors. Mol. Biol. Cell 23, 188-199
64. Pedram, A., Razandi, M., Sainson, R. C., Kim, J. K., Hughes, C. C., and Levin, E. R. (2007) A conserved mechanism for steroid receptor translocation to the plasma membrane. J. Biol. Chem. 282, 22278-22288
65. Mori, K., and Kato, H. (2002) A putative nuclear receptor coactivator (TMF/ARA160) associates with hbrm/hSNF2α and BRG-1/hSNF2β and localizes in the Golgi apparatus. FEBS Lett. 520, 127-132
66. Hsiao, P. W., and Chang, C. (1999) Isolation and characterization of ARA160 as the first androgen receptor N-terminal-associated coactivator in human prostate cells. J. Biol. Chem. 274, 22373-22379
67. Peyroche, A., Antonny, B., Robineau, S., Acker, J., Cherfils, J., and Jackson, C. L. (1999) Brefeldin A acts to stabilize an abortive ARFGDP-Sec7 domain protein complex: involvement of specific residues of the Sec7 domain. Mol. Cell 3, 275-285
68. Dehm, S. M., and Tindall, D. J. (2006) Molecular regulation of androgen action in prostate cancer. J. Cell. Biochem. 99, 333-344
69. Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pandey, A., and Chinnaiyan, A. M. (2004) ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6, 1-6
70. Tomlins, S. A., Mehra, R., Rhodes, D. R., Cao, X., Wang, L., Dhanasekaran, S. M., Kalyana-Sundaram, S., Wei, J. T., Rubin, M. A., Pienta, K. J., Shah, R. B., and Chinnaiyan, A. M. (2007) Integrative molecular concept modeling of prostate cancer progression. Nat. Genet. 39, 41-51
71. Wallace, T. A., Prueitt, R. L., Yi, M., Howe, T. M., Gillespie, J. W., Yfantis, H. G., Stephens, R. M., Caporaso, N. E., Loffredo, C. A., and Ambs, S. (2008) Tumor immunobiological differences in prostate cancer between African-American and European-American men. Cancer Res. 68, 927-936
72. Welsh, J. B., Sapinoso, L. M., Su, A. I., Kern, S. G., Wang-Rodriguez, J., Moskaluk, C. A., Frierson, H. F., Jr., and Hampton, G. M. (2001) Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 61, 5974-5978
73. Magee, J. A., Araki, T., Patil, S., Ehrig, T., True, L., Humphrey, P. A., Catalona, W. J., Watson, M. A., and Milbrandt, J. (2001) Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res. 61, 5692-5696
74. Singh, D., Febbo, P. G., Ross, K., Jackson, D. G., Manola, J., Ladd, C., Tamayo, P., Renshaw, A. A., D'Amico, A. V., Richie, J. P., Lander, E. S., Loda, M., Kantoff, P. W., Golub, T. R., and Sellers, W. R. (2002) Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 1, 203-209
75. Vanaja, D. K., Cheville, J. C., Iturria, S. J., and Young, C. Y. (2003) Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression. Cancer Res. 63, 3877-3882
76. Montgomery, B. T., Young, C. Y., Bilhartz, D. L., Andrews, P. E., Prescott, J. L., Thompson, N. F., and Tindall, D. J. (1992) Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP. Prostate 21, 63-73
77. Tosoian, J., and Loeb, S. (2010) PSA and beyond: the past, present, and future of investigative biomarkers for prostate cancer. ScientificWorld-Journal 10, 1919-1931
78. Wang, Y. N., Wang, H., Yamaguchi, H., Lee, H. J., Lee, H. H., and Hung, M. C. (2010) COPI-mediated retrograde trafficking from the Golgi to the ER regulates EGFR nuclear transport. Biochem. Biophys. Res. Commun. 399, 498-504
79. Vivithanaporn, P., Yan, S., and Swanson, G. T. (2006) Intracellular trafficking of KA2 kainate receptors mediated by interactions with coatomer protein complex I (COPI) and 14-3-3 chaperone systems. J. Biol. Chem. 281, 15475-15484
80. Chakrabarti, A., Chen, A. W., and Varner, J. D. (2011) A review of the mammalian unfolded protein response. Biotechnol. Bioeng. 108, 2777-2793
81. Razi, M., Chan, E. Y., and Tooze, S. A. (2009) Early endosomes and endosomal coatomer are required for autophagy. J. Cell Biol. 185, 305-321
82. Moore, S. M., and Nelson, P. S. (2002) Gene expression profiling of the human prostate androgen response program. J. Androl. 23, 163-169
83. Baek, S. H., Ohgi, K. A., Nelson, C. A., Welsbie, D., Chen, C., Sawyers, C. L., Rose, D. W., and Rosenfeld, M. G. (2006) Ligand-specific allosteric regulation of coactivator functions of androgen receptor in prostate cancer cells. Proc. Natl. Acad. Sci. U. S. A. 103, 3100-3105
84. Louie, M. C., Yang, H. Q., Ma, A. H., Xu, W., Zou, J. X., Kung, H. J., and Chen, H. W. (2003) Androgen-induced recruitment of RNA polymerase II to a nuclear receptor-p160 coactivator complex. Proc. Natl. Acad. Sci. U. S. A. 100, 2226-2230
85. Shang, Y., Myers, M., and Brown, M. (2002) Formation of the androgen receptor transcription complex. Mol. Cell 9, 601-610
86. Wang, Z., and Zhang, J. (2007) In search of the biological significance of modular structures in protein networks. PLoS Comput. Biol. 3, e107
87. Gingras, A. C., Gstaiger, M., Raught, B., and Aebersold, R. (2007) Analysis of protein complexes using mass spectrometry. Nat. Rev. Mol. Cell Biol. 8, 645-654
88. Landry, J. P., Fei, Y., and Zhu, X. (2012) Simultaneous measurement of 10, 000 protein-ligand affinity constants using microarray-based kinetic constant assays. Assay Drug Dev. Technol. 10, 250-259
89. Lipman, N. S., Jackson, L. R., Trudel, L. J., and Weis-Garcia, F. (2005) Monoclonal versus polyclonal antibodies: distinguishing characteristics, applications, and information resources. ILAR J. 46, 258-268
90. Keshishian, H., Addona, T., Burgess, M., Kuhn, E., and Carr, S. A. (2007) Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol. Cell. Proteomics 6, 2212-2229
91. Paliouras, M., Zaman, N., Lumbroso, R., Kapogeorgakis, L., Beitel, L. K., Wang, E., and Trifiro, M. (2011) Dynamic rewiring of the androgen receptor protein interaction network correlates with prostate cancer clinical outcomes. Integr. Biol. 3, 1020-1032
92. Zaman, N., Giannopoulos, P. N., Chowdhury, S., Bonneil, E., Thibault, P., Wang, E., Trifiro, M., and Paliouras, M. (2014) Proteomic-coupled-network analysis of T877A-androgen receptor interactomes can predict clinical prostate cancer outcomes between White (non-Hispanic) and African-American groups. PLoS One 9, e113190
93. Alexander, B., Fishman, A. I., Green, D., Choudhury, M. S., and Konno, S. (2013) Attenuation of androgenic regulation by brefeldin A in androgenresponsive prostate cancer cells. Urol. Oncol. 31, 104-109
94. Wallen, E., Sellers, R. G., and Peehl, D. M. (2000) Brefeldin A induces p53-independent apoptosis in primary cultures of human prostatic cancer cells. J. Urol. 164, 836-841
95. Miyajima, N., Maruyama, S., Bohgaki, M., Kano, S., Shigemura, M., Shinohara, N., Nonomura, K., and Hatakeyama, S. (2008) TRIM68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells. Cancer Res. 68, 3486-3494
96. Lange, V., Picotti, P., Domon, B., and Aebersold, R. (2008) Selected reaction monitoring for quantitative proteomics: a tutorial. Mol. Syst. Biol. 4, 222
97. Veldscholte, J., Berrevoets, C. A., Ris-Stalpers, C., Kuiper, G. G., Jenster, G., Trapman, J., Brinkmann, A. O., and Mulder, E. (1992) The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens. J. Steroid Biochem. Mol. Biol. 41, 665-669
98. Vlietstra, R. J., Van Alewijk, D. C., Hermans, K. G., Van Steenbrugge, G. J., and Trapman, J. (1998) Frequent inactivation of PTEN in prostate cancer cell lines and xenografts. Cancer Res. 58, 2720-2723
99. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S. H., Giovanella, B. C., Ittmann, M., Tycko, B., Hibshoosh, H., Wigler, M. H., and Parsons, R. (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943-1947
100. Sander, J. D., and Joung, J. K. (2014) CRISPR-Cas systems for editing, regulating and targeting genomes. Nat. Biotechnol. 32, 347-355
101. Barbieri, C. E., Baca, S. C., Lawrence, M. S., Demichelis, F., Blattner, M., Theurillat, J. P., White, T. A., Stojanov, P., Van Allen, E., Stransky, N., Nickerson, E., Chae, S. S., Boysen, G., Auclair, D., Onofrio, R. C., et al. (2012) Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat. Genet. 44, 685-689
102. Grasso, C. S., Wu, Y. M., Robinson, D. R., Cao, X., Dhanasekaran, S. M., Khan, A. P., Quist, M. J., Jing, X., Lonigro, R. J., Brenner, J. C., Asangani, I. A., Ateeq, B., Chun, S. Y., Siddiqui, J., Sam, L., et al. (2012) The mutational landscape of lethal castration-resistant prostate cancer. Nature 487, 239-243
103. Martinez, H. D., Jasavala, R. J., Hinkson, I., Fitzgerald, L. D., Trimmer, J. S., Kung, H. J., and Wright, M. E. (2008) RNA editing of androgen receptor gene transcripts in prostate cancer cells. J. Biol. Chem. 283, 29938-29949
104. Pfaffl, M. W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45